CClinicalTrials.gg
CompletedNCT04387643Updated May 14, 2020

Protecting Health Care Workers During the COVID-19 Outbreak

An observational study in Covid-19, sponsored by Aarogyam UK. Completed at 1 site in India. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-05-14.

Sponsored by Aarogyam UK · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
52
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Preparing to deal with Covid-19 outbreak in Rajasthan, India, health care workers were given Ayurvedic Kadha (combination of ayurvedic herbal extracts) starting from the end of February 2020. Then, majority of these health care workers were put on front line managing screening, monitoring, quarantine and treating Covid 19 patients. This real-life study aimed to determine the experience of health care workers who had Ayurveda kadha before starting as front-line workers.

02

Conditions studied

  • Covid-19

Browse trials for

03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 52 is below the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Aarogyam UK is the lead sponsor of 19 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Health care workers at front line of Covid-19 screening, treatment and management

Inclusion criteria

  • Health care workers posted in Covid-19 duties at front line
  • Health workers who had Ayurveda herbs combination over for at least 10-days

Exclusion criteria

Exclusion Criteria:

  • No willing to consent
  • inability to participate
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
52 participants (actual)
Patient registry
No

Interventions

  • Dietary supplementAyurvedic Kadha

    Kadha (also called Kwath and Kashaya) is a type of ayurvedic formulation prepared by boiling herbs in water. Water and herbs are main ingredients of these preparations. The preparation of Kadha uses dry herbs, which are dried under the sun or in the shade, as directed for the individual herb. Then, the herbs are pounded to form a coarse powder

06

What researchers measure

Primary outcomes

  1. Physical Health

    Self-reported health issues

    Time frame: From baseline to 30-days

  2. Psychological Health

    Self-reported psychological issues

    Time frame: From baseline to 30-days

Secondary outcomes

  1. Coping with distress

    Self-reported coping with high demanding work in Covid-19 duties

    Time frame: From baseline to 30-days

  2. Self-Help

    Self reported self-help measures used

    Time frame: From baseline to 30-days

07

Study locations

1 site
  • Samta Ayurveda Prakoshtha
    Jaipur, Rajasthan, India
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04387643
Lead sponsor
Aarogyam UK
Collaborators
Samta Ayurveda Prakoshtha, India
Responsible party
Sponsor
First posted
May 14, 2020
Start date
Mar 1, 2020
Primary completion
Apr 2, 2020
Completion
Apr 2, 2020
Last update
May 14, 2020

Study contacts

Neha Sharma
study chair · British Ayurvedic Medical Council (UK)
Jaydeep Joshi
study director · Aarogyam UK
Parashar Sharma
study director · Samta Ayurveda Prakoshtha, India
Sahil Singhal
principal investigator · Samta Ayurveda Prakoshtha, India

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion